20-16367663-T-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The ENST00000408042.5(KIF16B):āc.3662A>Gā(p.Gln1221Arg) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000825 in 1,612,620 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
ENST00000408042.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KIF16B | NM_024704.5 | c.3498+2923A>G | intron_variant | ENST00000354981.7 | NP_078980.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KIF16B | ENST00000408042.5 | c.3662A>G | p.Gln1221Arg | missense_variant | 23/23 | 1 | ENSP00000384164 | |||
KIF16B | ENST00000354981.7 | c.3498+2923A>G | intron_variant | 1 | NM_024704.5 | ENSP00000347076 | P1 | |||
KIF16B | ENST00000636835.1 | c.3345+2923A>G | intron_variant | 1 | ENSP00000489838 | |||||
KIF16B | ENST00000635823.2 | c.4982A>G | p.Gln1661Arg | missense_variant | 23/23 | 5 | ENSP00000490639 |
Frequencies
GnomAD3 genomes AF: 0.0000460 AC: 7AN: 152176Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000999 AC: 24AN: 240348Hom.: 0 AF XY: 0.000129 AC XY: 17AN XY: 131996
GnomAD4 exome AF: 0.0000863 AC: 126AN: 1460326Hom.: 0 Cov.: 32 AF XY: 0.0000922 AC XY: 67AN XY: 726434
GnomAD4 genome AF: 0.0000460 AC: 7AN: 152294Hom.: 0 Cov.: 33 AF XY: 0.0000269 AC XY: 2AN XY: 74462
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 13, 2024 | The c.3662A>G (p.Q1221R) alteration is located in exon 23 (coding exon 23) of the KIF16B gene. This alteration results from a A to G substitution at nucleotide position 3662, causing the glutamine (Q) at amino acid position 1221 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at